Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: NEJM Evid. 2023 Feb 27;2(3):10.1056/evidoa2200302. doi: 10.1056/evidoa2200302

Figure 1.

Figure 1.

Percentage of Participants Receiving ART and Percentage with HIV RNA Levels 200 copies/ml.

(Panel A) Summary of percentage of participants receiving antiretroviral therapy (ART) and percentage with HIV RNA levels ≤200 copies (cp)/ml according to month of follow-up after randomization in the pre-2016 period. (Panel B) Summary of percentage of participants receiving ART and percentage with HIV RNA levels ≤200 cp/ml according to calendar year of follow-up in the post–January 1, 2016, period.